Interim Chief Medical Officer: Dr Naftali Bechar

Naftali Bechar trained as a medical oncologist at Memorial Sloan Kettering Cancer Center, New York, where he then served as a Chief Resident. He subsequently practised as a medical oncologist for 15 years in Indiana, during which time he was involved in oncology Phase 2 and Phase 3 cooperative clinical research. In 2014 he joined the pharmaceutical industry working on pre-clinical gap analysis, clinical protocol development, IND submissions and medical monitoring for oncology and immune-oncology Phase 1 clinical trials. Naftali joined PsiOxus in 2019 as Executive Medical Director.

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image